vs

Side-by-side financial comparison of RMR GROUP INC. (RMR) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

RMR GROUP INC. is the larger business by last-quarter revenue ($66.7M vs $35.5M, roughly 1.9× RECURSION PHARMACEUTICALS, INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs -304.2%, a 322.5% gap on every dollar of revenue. On growth, RECURSION PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (681.7% vs 40.8%).

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

RMR vs RXRX — Head-to-Head

Bigger by revenue
RMR
RMR
1.9× larger
RMR
$66.7M
$35.5M
RXRX
Growing faster (revenue YoY)
RXRX
RXRX
+641.0% gap
RXRX
681.7%
40.8%
RMR
Higher net margin
RMR
RMR
322.5% more per $
RMR
18.3%
-304.2%
RXRX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
RMR
RMR
RXRX
RXRX
Revenue
$66.7M
$35.5M
Net Profit
$12.2M
$-108.1M
Gross Margin
59.8%
Operating Margin
48.1%
-304.8%
Net Margin
18.3%
-304.2%
Revenue YoY
40.8%
681.7%
Net Profit YoY
91.1%
39.6%
EPS (diluted)
$0.71
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RMR
RMR
RXRX
RXRX
Q4 25
$66.7M
$35.5M
Q3 25
$5.2M
Q2 25
$19.2M
Q1 25
$14.7M
Q4 24
$4.5M
Q3 24
$26.1M
Q2 24
$14.4M
Q1 24
$13.8M
Net Profit
RMR
RMR
RXRX
RXRX
Q4 25
$12.2M
$-108.1M
Q3 25
$-162.3M
Q2 25
$-171.9M
Q1 25
$-202.5M
Q4 24
$-178.9M
Q3 24
$-95.8M
Q2 24
$-97.5M
Q1 24
$-91.4M
Gross Margin
RMR
RMR
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
-4.9%
Q1 25
-48.0%
Q4 24
-181.4%
Q3 24
53.7%
Q2 24
36.2%
Q1 24
19.1%
Operating Margin
RMR
RMR
RXRX
RXRX
Q4 25
48.1%
-304.8%
Q3 25
-3327.6%
Q2 25
-916.8%
Q1 25
-1297.9%
Q4 24
-4042.4%
Q3 24
-377.1%
Q2 24
-697.4%
Q1 24
-698.4%
Net Margin
RMR
RMR
RXRX
RXRX
Q4 25
18.3%
-304.2%
Q3 25
-3135.3%
Q2 25
-894.2%
Q1 25
-1373.3%
Q4 24
-3935.5%
Q3 24
-367.5%
Q2 24
-676.6%
Q1 24
-662.4%
EPS (diluted)
RMR
RMR
RXRX
RXRX
Q4 25
$0.71
$-0.17
Q3 25
$-0.36
Q2 25
$-0.41
Q1 25
$-0.50
Q4 24
$-0.56
Q3 24
$-0.34
Q2 24
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RMR
RMR
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$49.3M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$232.7M
$1.1B
Total Assets
$687.1M
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RMR
RMR
RXRX
RXRX
Q4 25
$49.3M
$743.3M
Q3 25
$659.8M
Q2 25
$525.1M
Q1 25
$500.5M
Q4 24
$594.4M
Q3 24
$427.6M
Q2 24
$474.3M
Q1 24
$296.3M
Total Debt
RMR
RMR
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
RMR
RMR
RXRX
RXRX
Q4 25
$232.7M
$1.1B
Q3 25
$1.0B
Q2 25
$919.1M
Q1 25
$933.9M
Q4 24
$1.0B
Q3 24
$524.6M
Q2 24
$584.4M
Q1 24
$401.2M
Total Assets
RMR
RMR
RXRX
RXRX
Q4 25
$687.1M
$1.5B
Q3 25
$1.4B
Q2 25
$1.3B
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$726.5M
Q2 24
$775.9M
Q1 24
$557.8M
Debt / Equity
RMR
RMR
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RMR
RMR
RXRX
RXRX
Operating Cash FlowLast quarter
$10.7M
$-46.1M
Free Cash FlowOCF − Capex
$-47.3M
FCF MarginFCF / Revenue
-133.1%
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RMR
RMR
RXRX
RXRX
Q4 25
$10.7M
$-46.1M
Q3 25
$-117.4M
Q2 25
$-76.4M
Q1 25
$-132.0M
Q4 24
$-115.4M
Q3 24
$-59.2M
Q2 24
$-82.2M
Q1 24
$-102.3M
Free Cash Flow
RMR
RMR
RXRX
RXRX
Q4 25
$-47.3M
Q3 25
$-117.6M
Q2 25
$-79.6M
Q1 25
$-133.8M
Q4 24
$-116.7M
Q3 24
$-63.8M
Q2 24
$-83.4M
Q1 24
$-109.0M
FCF Margin
RMR
RMR
RXRX
RXRX
Q4 25
-133.1%
Q3 25
-2272.5%
Q2 25
-413.9%
Q1 25
-907.4%
Q4 24
-2567.7%
Q3 24
-244.6%
Q2 24
-578.5%
Q1 24
-789.9%
Capex Intensity
RMR
RMR
RXRX
RXRX
Q4 25
3.5%
Q3 25
4.7%
Q2 25
16.4%
Q1 25
12.4%
Q4 24
28.6%
Q3 24
17.5%
Q2 24
8.2%
Q1 24
48.2%
Cash Conversion
RMR
RMR
RXRX
RXRX
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons